R3 Stem Cell Now Offering Amniotic Membrane Allograft for Effective...
Regenerative medicine company R3 Stem Cell is now offering amniotic membrane allograft for eye care treatment. The membranes are safe, effective, FDA regulated and excellent for all types of...(PRWeb October 23, 2017)Read the full story at http://www.prweb.com/releases/amnioticmembraneallograft/r3-stem-cell/prweb14831115.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 23, 2017 Category: Pharmaceuticals Source Type: news
NuVasive Receives Expanded FDA 510(k) Clearance For TLX Interbody System Used In TLIF Procedures
New clearance for TLX system includes indications for use with allogeneic bone graft and in additional levels of the spine; Technology to be showcased at NASS 2017
SAN DIEGO, Oct. 16, 2017 -- (Healthcare Sales & Marketing Network) -- NuVasive, Inc. (N... Devices, Neurosurgery, Orthopaedic, FDA NuVasive, TLX interbody, TLIF, spine surgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 16, 2017 Category: Pharmaceuticals Source Type: news
FDA expands indication for NuVasive ’ s TLX spine implant
NuVasive Inc. (NSDQ:NUVA) said today the it won expanded 510(k) clearance from the FDA for its TLX implant used in spinal fusion surgery.
San Diego-based NuVasive said the new clearance covers an new, expandable 20° cage and new indications for use covering allogeneic bone grafts and more spine levels.
“With the additional clearance for our latest TLX system, we now provide the leading tools for [transforaminal lumbar interbody fusion] procedures with our MAS TLIF solution, validating our commitment to improving spine solutions,” strategy, technology & corporate development EVP Matt Link said in prepared ...
Source: Mass Device - October 16, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Food & Drug Administration (FDA) Orthopedics Regulatory/Compliance Spinal Nuvasive Source Type: news
Hamstring autograft with preserved insertions linked to improved outcomes compared to free autograft for ACL patients
A study published online in the journal Arthroscopy compares differences in short-term outcomes for patients who undergo anterior cruciate ligament (ACL) reconstruction using a graft with preserved insertions and those treated with a free hamstring graft. (Source: Orthogate - Latest News)
Source: Orthogate - Latest News - October 15, 2017 Category: Orthopaedics Tags: Featured Editors Choice News Source Type: news
Dr. Gloria Matthews Joins MiMedx As Its Senior Vice President Of Research And Development
MIMEDX REAFFIRMS LATEST THIRD QUARTER OF 2017 REVENUE EXPECTATIONS
MARIETTA, Ga., Oct. 3, 2017 -- (Healthcare Sales & Marketing Network) -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative a... Devices, Regenerative Medicine, Personnel MiMedx Group, PURION, placental tissue allograft (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 3, 2017 Category: Pharmaceuticals Source Type: news
OSTEOPOROSIS: How weak bones could leave you inches shorter
WHEN Christine Howis broke her arm at the age of 51, she thought it was no more than an accident – even though she eventually needed a bone graft when it failed to heal properly. (Source: Daily Express - Health)
Source: Daily Express - Health - September 26, 2017 Category: Consumer Health News Source Type: news
Treatment of Large Bone Defect from Root Fracture
In this case, a large bone defect, as a consequence of fractured roots of the first molar, was augmented by Bond Apatite bone graft cement. (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - September 25, 2017 Category: Dentistry Authors: osseonews Tags: Clinical Cases Regenerative Source Type: news
Tiny diamonds could become best friends to youths with cleft palates
This study showed that our method has a contained, targeted and sustained effect, so we’re very excited about it,” Hong said.Previous experiments showed nanodiamonds to be safe within the body and to be excreted normally. Similarly, earlier work demonstrated that enzymes break down hydrogel.The researchers plan to continue laboratory studies and hope to bring their treatment to clinical trials. Their approach has implications for treating other craniofacial conditions and sleep apnea, as well as healing wounds and bone injuries.Other authors of the study were Dong-Keun Lee, Lawrence Lin, Hsin Chuan Pan, Deborah Lee, Pe...
Source: UCLA Newsroom: Health Sciences - September 22, 2017 Category: Universities & Medical Training Source Type: news
Will Small Companies See a Bigger Impact from Hurricanes?
Cardiovascular Systems Inc. said Monday that its procedure volumes took a hit in the Houston, TX, and Florida markets, which account for more than 15% of the company’s revenue, in the aftermath of Hurricanes Harvey and Irma. To add insult to injury, the company reported that September is normally its strongest month for procedures within the quarter, which means the fiscal first quarter revenues are more heavily weighted in September. The company is based in St. Paul, MN, but has a facility in Pearland, TX, near Houston.
"As recovery progresses, we will closely monitor conditions and the anticipated impact on our busi...
Source: MDDI - September 19, 2017 Category: Medical Devices Authors: Amanda Pedersen Tags: MD & M Minneapolis Medical Device Business Source Type: news
MiMedx loses appeal in placental allograft tissue patent spat
A Federal Circuit Court this week affirmed a Patent Trial and Appeal Board ruling which found a MiMedx (NSDQ:MDXG) tissue graft patent invalid in a spat between the company and the Musculoskeletal Transplant Foundation.
The ruling came from a 3-judge panel, delivered in a 1-line order without an opinion, affirming the PTAB’s decision from last month which found the patent as invalid as obvious, according to court documents.
The spat is related to a dehydrated human amnion/chorion membrane placental tissue allograft patent, with Marietta, Ga.-based MiMedx claiming that the MTF infringed upon it with their own grafts.
In ...
Source: Mass Device - September 15, 2017 Category: Medical Devices Authors: Fink Densford Tags: Legal News Patent Infringement MiMedx Group Inc. Source Type: news
MiMedx Notified By FDA That It Can Proceed With Phase 3 Investigational New Drug Clinical Trial For Achilles Tendonitis
MARIETTA, Ga., Sept. 7, 2017 -- (Healthcare Sales & Marketing Network) -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts ... Biopharmaceuticals, Regenerative Medicine, Orthopaedic, FDA MiMedx Group, AmnioFix, achilles tendonitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 7, 2017 Category: Pharmaceuticals Source Type: news
Never say never again: a bone graft infection due to a hornet sting, thirty-nine years after cranioplasty - Maugeri R, Giammalva RG, Graziano F, Basile L, Gul ì C, Giugno A, Iacopino DG.
BACKGROUND: Cranioplasty (CP) is a widespread surgical procedure aimed to restore skull integrity and physiological cerebral hemodynamics, to improve neurological functions and to protect the underlying brain after a life-saving decompressive craniectomy (... (Source: SafetyLit)
Source: SafetyLit - September 7, 2017 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
MassDevice.com +5 | The top 5 medtech stories for September 5, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. How medical device risk management is connected with design controls
Medical device design controls play an important role when it comes to risk management, but the relationship isn’t always immediately clear.
Intended use is...
Source: Mass Device - September 5, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news
Medtronic launches long-term PLF, TLIF Infuse bone protein study
Medtronic (NYSE:MDT) said today it launched a long-term clinical study of its Infuse bone graft for use during posterolateral fusion and transforaminal lumbar interbody fusion spine procedures.
The 1st patient in the study was enrolled at Indiana’s Fort Wayne Orthopedics and underwent a procedure led by Dr. Kevin Rahn and Dr. Robert Shugart, Fridley, Minn.-based Medtronic said.
“Failed back surgery is a real concern with long-term implications, and successful outcomes in PLF and TLIF procedures require solid fusion. We believe there is significant data on the safety and efficacy profile of Infuse in approved A...
Source: Mass Device - September 5, 2017 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Spinal Medtronic Source Type: news
Bone Binders for bone augmentation?
Do you know of any bone binders used in oral bone augmentation procedures that would not interfere with osteogenesis, resorb parallel with bone graft material and be biologically inert? (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - August 30, 2017 Category: Dentistry Authors: osseonews Tags: Clinical Questions Regenerative Source Type: news
